Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker.
Israel’s RedHill Biopharma Ltd. is licensing EU rights to its gastrointestinal drug Movantik (naloxegol) as well as one of...








